Incomplete Response in Late-Life Depression: Getting to Remission With Buprenorphine
Phase of Trial: Phase I/II
Latest Information Update: 07 Jun 2019
Price : $35 *
At a glance
- Drugs Buprenorphine (Primary) ; Venlafaxine (Primary)
- Indications Depression; Depressive disorders
- Focus Adverse reactions; Therapeutic Use
- Acronyms IRL Grey B
- 11 Sep 2018 Status changed from recruiting to completed.
- 02 Aug 2016 Status changed from not yet recruiting to recruiting.
- 26 Apr 2016 Planned End Date changed from 1 Dec 2017 to 1 Aug 2018.